Saltar al contenido
Merck
Todas las fotos(1)

Documentos

59352-U21

Supelco

Discovery® C8 (5 µm) HPLC Columns

L × I.D. 5 cm × 2.1 mm, HPLC Column

Sinónimos:

C8 Reversed-Phase Chromatography Column

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(1)

About This Item

Código UNSPSC:
41115700
eCl@ss:
32110501
NACRES:
SB.52

product name

Columna para HPLC Discovery® C8, 5 μm particle size, L × I.D. 5 cm × 2.1 mm

Materiales

stainless steel column

Agency

suitable for USP L7

Línea del producto

Discovery®

Características

endcapped

fabricante / nombre comercial

Discovery®

envase

1 ea of

Extensión del etiquetado

7.5% Carbon loading

Parámetros

≤70 °C temp. range
400 bar pressure (5801 psi)

técnicas

HPLC: suitable
LC/MS: suitable

L × D.I.

5 cm × 2.1 mm

superficie

200 m2/g

cobertura de la superficie

3.4 μmol/m2

impurezas

<10 ppm metals

matriz

silica gel, high purity, spherical base material
fully porous particle

grupo activo de la matriz

C8 (octyl) phase

tamaño de partícula

5 μm

tamaño de poro

180 Å

operating pH range

2-8

aplicaciones

food and beverages

técnica de separación

reversed phase

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Aplicación


  • UHPLC-MS/MS method for chiral separation of 3-hydroxy fatty acids: Highlighting the adaptability of the Discovery® C8 column, this paper details its application in a sophisticated chiral separation method, underscoring its importance in clinical diagnostics and research (Fu et al., 2023).

Características y beneficios

Características de la Discovery® C8:
• Selectividad y retención clásica C18
• Excelente forma del pico
• Estable, separaciones CL/EM (LC/MS) sin sangrado
• Similar selectividad que la C18, con menor retención hidrófoba.

Información legal

Discovery is a registered trademark of Merck KGaA, Darmstadt, Germany

Producto relacionado

Referencia del producto
Descripción
Precios

Choose from one of the most recent versions:

Certificados de análisis (COA)

Lot/Batch Number
281567-02
281567-01
281563-02
281563-01
279685-02

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Scott C Bell et al.
Pharmacology & therapeutics, 145, 19-34 (2014-06-17)
With the discovery of the CFTR gene in 1989, the search for therapies to improve the basic defects of cystic fibrosis (CF) commenced. Pharmacological manipulation provides the opportunity to enhance CF transmembrane conductance regulator (CFTR) protein synthesis and/or function. CFTR
Bo-Rui Kang et al.
Bioorganic & medicinal chemistry letters, 25(24), 5808-5812 (2015-11-08)
2-Benzylisoquinolin-1(2H)-ones has been proposed as vasodilative agents on the basis of scaffold hopping. In the present study, a series of 2-benzylisoquinolin-1(2H)-ones were synthesized. Their vasodilative effects were evaluated by wire myograph on isolated rat mesenteric arterial ring induced contraction with
Hugo M Botelho et al.
Scientific reports, 5, 9038-9038 (2015-03-13)
Plasma membrane proteins are essential molecules in the cell which mediate interactions with the exterior milieu, thus representing key drug targets for present pharma. Not surprisingly, protein traffic disorders include a large range of diseases sharing the common mechanism of
M Q Zhang et al.
Die Pharmazie, 46(10), 687-700 (1991-10-01)
The rapid growth in the quinolone research changed the whole face of the previous SAR concepts. So far structural modifications at all positions of the quinolone nucleus except the 4-oxo group have successfully lead to the discovery of potent antimicrobial
G L Bundy et al.
The Journal of biological chemistry, 261(2), 747-751 (1986-01-15)
The gorgonian coral Pseudoplexaura porosa contains a lipoxygenase capable of converting exogenous arachidonic acid into (8R)-8-hydroperoxy-5,9,11,14-eicosatetraenoic acid. The (8R)- (or 8-L-) configuration in this product, opposite to that observed in previously reported 8-lipoxygenase products, was determined unambiguously by comparison of
Ver todos los artículos relacionados

Contenido relacionado

Discovery C18 and C8 HPLC Columns

Discovery C18 and C8 HPLC Columns products offered

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico